Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Allen Patricia L
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Alnylam Pharmaceuticals Inc.
Deciphera Pharmaceuticals, Inc.
Kineta, Inc./de
Larimar Therapeutics, Inc.
Alnylam Pharmaceuticals Inc.
VP of Finance and Treasurer
Avg. Two Year Performance
No Purchase Track Record
49%
Avg. Sale Return
22%
Compound
Holdings:
0.65K
shares
Last Three Months: 17-Feb-24 -- 16-May-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
17-May-22 -- 16-May-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions